Interleukin-6 Receptor Antagonist [EPC]

138631 reported adverse events

Drugs of this class: TOCILIZUMAB TOCILIZUMAB-AAZG SARILUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-6 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 39318
1 RHEUMATOID ARTHRITIS 24972
2 PAIN 24192
3 OFF LABEL USE 21459
4 ARTHRALGIA 21017
5 JOINT SWELLING 18640
6 FATIGUE 16641
7 RASH 14724
8 DRUG INTOLERANCE 13383
9 CONTRAINDICATED PRODUCT ADMINISTERED 12411
See all common reactions for Interleukin-6 Receptor Antagonist [EPC]

Drugs of the Interleukin-6 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 310 0.9226
1 DISABILITY ASSESSMENT SCALE SCORE INCREASED 267 0.8697
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6111 0.8521
3 SWOLLEN JOINT COUNT INCREASED 2646 0.8289
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 552 0.8263
5 RHEUMATOID FACTOR POSITIVE 4690 0.8111
6 RHEUMATIC FEVER 3526 0.7902
7 PEMPHIGUS 9469 0.7566
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 1503 0.7504
9 C-REACTIVE PROTEIN 666 0.7184
See all enriched reactions for Interleukin-6 Receptor Antagonist [EPC]